Spark Therapeutics Competitors and Similar CompaniesClear all

Spark Therapeutics's competitors and similar companies include Bruker Cellular Analysis, ImmusanT and Genclis.
Spark Therapeutics
Spark Therapeutics
Spark Therapeutics is a gene therapy company.
Bruker Cellular Analysis
Bruker Cellular Analysis
Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.
ImmusanT
ImmusanT
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
Genclis
Genclis
Genclis is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (TI).
Founding Date
Founding Date
2013
Founding Date
2011
Founding Date
2010
Founding Date
2004
Type
Type
Public
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Philadelphia, US HQ
Locations
Emeryville, US HQ
Locations
Cambridge, US HQ
Locations
Vandœuvre-lès-Nancy, FR HQ
Employees
Employees
36817% increase
Employees
1391% decrease
Employees
2
Employees
6

Financial

Revenue (est.)
Revenue (est.)
$64.7m (FY, 2018)
Revenue (est.)
$78.6m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($78.8m) (FY, 2018)
Net income
($98m) (FY, 2022)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 122.8m
Total funding raised
$ 124.7m
Total funding raised
$ 72.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Bruker Cellular Analysis
HQ
Emeryville, US

Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.

View company
ImmusanT
HQ
Cambridge, US
Employees
2

ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.

View company
Genclis
HQ
Vandœuvre-lès-Nancy, FR
Employees
6

Genclis is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (TI).

View company